City St George’s

Child having ultrasound on knee
#Biopharma #City St George's #Osteoarthritis

City St George’s partners to develop new osteoarthritis drug 

City St George’s is partnering with drug development company Paradigm Biopharmaceuticals to test a drug that could become a new treatment option for osteoarthritis.  The UK-Australian partnership will investigate the effect of injectable pentosan polysulfate sodium (iPPS) – a drug currently being trialled for knee osteoarthritis by Paradigm Biopharmaceuticals… Read More

#News